Safety, Efficacy and Tolerability of BAF312 in Patients with Stroke due to Intracerebral Hemorrhage
A double blind, randomized, placebo-controlled phase II trial for Novartis (siponimod) in patients with intracerebral hemorrhage
Project Type: Research
Year started: 2021
Diagnosis: Stroke